Joel Gelfand, MD, MSCE

Professor of Dermatology and of Epidemiology,

Vice Chair of Clinical Research and Medical Director,

Dermatology Clinical Studies Unit

Director, Psoriasis and Phototherapy Treatment Center

Perelman School of Medicine

University of Pennsylvania

Philadelphia, Pennsylvania

Richard Martin, MD, MA

Professor of Medicine and Rheumatology,

Michigan State University College of Human Medicine

East Lansing, Michigan

Activity Information

Activity Description

Improving care for patients with psoriatic disease and atopic dermatitis (AD) is profoundly boosted by facilitating better patient-provider communication and implementing targeted treatment strategies. Deep Discovery enhances participants’ adeptness in these areas through innovative experiential learning and presentations. The multiprofessional team of presenters will demonstrate mechanisms of action of therapies using a HoloLens—a mixed-reality device. They will also discuss effectiveness and safety of existing and emerging targeted treatments for psoriasis, psoriatic arthritis (PsA), and AD and elaborate on shared decision making. Learners will gain expertise in the main pathways of immune activation and build inspiration to translate recent scientific advances into patient-centered care.

 

Target Audience

The target audience for this activity is dermatologists, physician assistants, and nurse practitioners who specialize in dermatology. Other healthcare professionals providing care for patients with psoriasis, PsA, and AD may benefit from participation in this educational activity.

Focusing in-depth on treatment strategies for psoriasis, psa, and ad

Thursday, November 7, 2019

9:30AM-10:30AM

The Cosmopolitan of Las Vegas

Belmont 2,3,6,7  |  Las Vegas, Nevada

This symposium is independently organized and not an official part of Skin Disease Education Foundation's (SDEF) 20th Annual Las Vegas Dermatology Seminar®. CME/CE credit is provided for this symposium.

Faculty

Credit Designation Statement

Forefront Collaborative designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Accreditation Statement

Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Disclosure Statement

Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). The disclosures will be listed in the activity handout.

Welcome and Session Overview

 

HoloLens Experience: The Main Pathways of Immune Activation and Targeted Therapies in Atopic Dermatitis and Psoriasis

Joel Gelfand, MD, MSCE, and Richard Martin, MD, MA

 

Targeted Therapies in Atopic Dermatitis, Psoriasis, and Psoriatic Arthritis

Joel Gelfand, MD, MSCE

 

Using Shared Decision Making to Align Treatment With Patient Goals in Psoriatic Arthritis

Richard Martin, MD, MA

 

Question and Answer Session

Facilitated by Joel Gelfand, MD, MSCE, and Richard Martin, MD, MA

 

Closing Remarks

Agenda

Learning Objectives

CME Information

Describe current models explaining pathophysiology of psoriasis, psoriatic arthritis (PsA), and atopic dermatitis (AD)

Apply evolving treatment strategies and guiding principles to management of patients with psoriasis/PsA or AD

Identify mechanisms of action (MOAs), effectiveness, and safety of existing and emerging targeted treatments for psoriasis, PsA, and AD

Upon completion of this activity, participants should be  able to

Engage patients with psoriatic disease or AD in shared decision making regarding treatment goals, treatment plan, and treatment modification

Download live activity resources and claim your CME credit.

Downloads

630 W. Carmel
Drive, Suite 260

Carmel, Indiana 46032

P 317.814.3126

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative and Lilly.

 

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

 

Focusing in-depth on treatment strategies for psoriasis, psa, and ad

Focusing in-depth on treatment strategies for psoriasis, psa, and ad

Download live activity resources and claim your CME credit.

Focusing in-depth on treatment strategies for psoriasis, psa, and ad